NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY]

Side Effects & Adverse Event Reports


0

Adverse Events

0

Side Effects

2025

Data Starting In

This report has a limited number of adverse event reports which may not fully reflect the safety profile of this product. It's important to understand that:

  • Only manufacturers are required to report adverse events — for everyone else, reporting is voluntary.
  • It's estimated that only about 10% of adverse events are ever reported.
  • Some people may not realize their experience qualifies as an adverse event.
  • Others may assume someone else has already reported the issue.
  • A lack of awareness about how and where to report can also reduce submissions.
Your report can help close this gap. Whether your experience was mild or serious, sharing it contributes to a fuller understanding of product safety and can help others make better health decisions.

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY].

Understanding the potential Side Effects and Adverse Events of NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY] is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY] may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY] are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY]?

    NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY] has 0 adverse event reports in this SymPedia dataset.

  • How many side effects have been reported for NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY]?

    NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY] has 0 side effect reports in this SymPedia dataset.

  • What year does the NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY] reporting data start?

    The reporting data on this page starts in 2025.

  • What years are included in the yearly chart for NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION [PENMENVY]?

    Yearly chart data is not available for this page.

  • Is adverse event reporting mandatory?

    Only manufacturers are required to report adverse events. For other reporters, submission is generally voluntary, which can lead to underreporting.

NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION

Side Effects & Adverse Event Reports


0

Adverse Events

0

Side Effects

2025

Data Starting In

This report has a limited number of adverse event reports which may not fully reflect the safety profile of this product. It's important to understand that:

  • Only manufacturers are required to report adverse events — for everyone else, reporting is voluntary.
  • It's estimated that only about 10% of adverse events are ever reported.
  • Some people may not realize their experience qualifies as an adverse event.
  • Others may assume someone else has already reported the issue.
  • A lack of awareness about how and where to report can also reduce submissions.
Your report can help close this gap. Whether your experience was mild or serious, sharing it contributes to a fuller understanding of product safety and can help others make better health decisions.

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION.

Understanding the potential Side Effects and Adverse Events of NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION?

    NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION has 0 adverse event reports in this SymPedia dataset.

  • How many side effects have been reported for NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION?

    NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION has 0 side effect reports in this SymPedia dataset.

  • What year does the NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION reporting data start?

    The reporting data on this page starts in 2025.

  • What years are included in the yearly chart for NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.02 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT FHBP FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NADA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT NHBA FUSION PROTEIN ANTIGEN 0.1 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 0.05 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML / NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE 0.01 MG/ML INJECTION?

    Yearly chart data is not available for this page.

  • Is adverse event reporting mandatory?

    Only manufacturers are required to report adverse events. For other reporters, submission is generally voluntary, which can lead to underreporting.